New Delhi-headquartered venture capital firm Venture Highway has raised $78.6 million for its second fund, which will focus on early-stage investments in technology start-ups.
Founded in 2015, Venture Highway constitutes a five-person team led by Samir Sood (pictured), a former Google and Cisco Systems investment executive. The firm has backed over 30 Indian start-ups so far....
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.